David C. Grimsditch

403 citations
16 papers · 315 · h-index 10

Impact in

    • Atherosclerosis and Cardiovascular Diseases
    • Complement system in diseases
    • Phagocytosis and Immune Regulation
    • Immune cells in cancer

Papers in

    • Peroxisome Proliferator-Activated Receptors 3
    • Phosphodiesterase function and regulation 3
    • Atherosclerosis and Cardiovascular Diseases 4

David C. Grimsditch

16 papers receiving 307 citations

Peers

David C. Grimsditch
Comparison fields: 5 of 66
  • Immunology 134
  • Physiology 52
  • Biochemistry 12
  • Hematology 17
  • Molecular Biology 102
Replace David H. McMillan with:
David H. McMillan United States
Ryoko Shiga Japan
Dae‐Weon Park South Korea
Mark Burgert United States
Harukuni Akita Japan
Hans P. Deigner Germany
Lijiang Shen United States
В. В. Соболев Russia
T. Navin United Kingdom
Kouichi Fukunaga Japan
David C. Grimsditch relative to David H. McMillan United States David H. McMillan's profile →
Citations per field
00.5×1.5×1.8×
David H. McMillan · 1×
Citations per year

Countries citing papers authored by David C. Grimsditch

Since Specialization
Citations

This map shows the geographic impact of David C. Grimsditch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Grimsditch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Grimsditch more than expected).

Fields of papers citing papers by David C. Grimsditch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Grimsditch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Grimsditch. The network helps show where David C. Grimsditch may publish in the future.

Co-authors

The 25 scholars most cited alongside David C. Grimsditch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David C. Grimsditch Line = papers co-authored together David C. Grimsditch links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2007127
2 201032
3 200032
4 199220
5
Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.
199115
6 200514
7 200314
8 200312
9 200012
10 20049
11 20027
12
La construccion de instituciones democraticas : sistemas de partidos en América Latina
19967
13 20045
14 19944
15 19973
16 19972

About David C. Grimsditch

David C. Grimsditch is a scholar working on Molecular Biology, Immunology, Surgery, Oncology and Physiology, having authored 16 papers that have together received 315 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Phosphodiesterase function and regulation (3 papers), Cholesterol and Lipid Metabolism (3 papers), Cancer, Lipids, and Metabolism (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Immunology (134 citations), Physiology (52 citations), Biochemistry (12 citations), Hematology (17 citations) and Molecular Biology (102 citations). David C. Grimsditch has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include G. Martin Benson, Vinay K. Bhatia, Marina Botto, Sheng Yun, Dorian O. Haskard, Joseph J. Boyle, Martin Vidgeon-Hart, Pieter H.E. Groot, Philip Overend and David G. Reid. Their work appears in journals such as Atherosclerosis, British Journal of Pharmacology, Biochemical Society Transactions, Arteriosclerosis Thrombosis and Vascular Biology and Disease Markers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact